Delivery Order SPE2DB22D2214-SPE2DB25FS6BW
- Not listed
- The U.S. Defense Logistics Agency, through its Medical Supply Chain, awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of OxyContin ER 80 mg tablets (100-count units) valued at $1,796.20. This is a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, representing a single-transaction purchase of pharmaceutical inventory. The contract was competitively awarded without set-aside designation, leveraging...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 27, 2025, for OxyContin ER 30 mg tablets (100-count units) with a ceiling value of $1,717.40. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 28, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,007.92 on September 12, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units). The contract is competitively awarded with no set-aside designation and features firm fixed pricing, with an ultimate completion date of September 15, 2025. The award is funded by the Defense Logistics Agency's Medical Supply Chain, a division of the...
- The Defense Logistics Agency awarded a delivery order valued at $4,061.29 to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of OxyContin ER 80 mg tablets (100-count units). The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award, and is scheduled for completion by August 29, 2025. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of OxyContin ER 10 mg tablets (100-count) valued at $3,143.30. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 7, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of OxyContin ER 20 mg tablets in quantities of 100 units. The contract is valued at $3,667.68 with a firm fixed-price structure and is scheduled for completion by August 6, 2025. This competitively awarded delivery order carries no set-aside designation and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $2,370.38 delivery order contract on September 18, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units). The contract is structured as a firm fixed-price delivery order with a completion date of September 19, 2025, and represents a non-set-aside competitive award. The awardee will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,300.23 to AmerisourceBergen Drug Corp for OxyContin ER 80 mg tablets (100-count packaging) on September 5, 2025, with an ultimate completion date of September 8, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $5,072.23 for OxyContin tablets (20mg) by the Department of Defense Medical Supply Chain, with an award date of October 5, 2025, and ultimate completion by October 6, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on June 17, 2025, for OxyContin ER 20 mg tablets (100-count bottles) with a ceiling value of $1,120.98. This is a firm fixed-price delivery order with an ultimate completion date of June 18, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS6BWDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 11, 2025, for the supply of OxyContin ER 80 mg tablets (100-count units) valued at $5,025.57. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance is scheduled for completion by August 12, 2025, with the product to be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. This delivery order represents a child contract under AmerisourceBergen's broader relationship with the DLA. This award falls under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including support for the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio demonstrates its established capability to fulfill competitive pharmaceutical procurement requirements across multiple therapeutic domains through the DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 8/11/25 |